People Funding or Working in Age Reversal

There are a growing number of people who are working on or funding research into human age reversal, with the goal of developing therapies to extend a healthy lifespan and reduce the burden of age-related diseases.

These individuals and organizations are helping to drive the development of new age-reversal therapies, which could have a transformative impact on human health and well-being.

By investing in research and development, they are helping to create a future in which people can live longer, healthier lives free from the burdens of age-related diseases.

Their work represents a bold and visionary approach to one of the greatest challenges facing humanity, and their efforts are sure to be closely watched and supported in the years to come.

the table below lists some of the people working or investing in this exciting field.

NameWork or Funding
Aubrey de GreyFounder of the SENS Research Foundation, focused on developing regenerative medicine therapies to treat age-related disease
Laura DemingFounder of The Longevity Fund, an early-stage venture capital firm investing in companies working on age-related diseases
Jim MellonCo-founder of Juvenescence, an investment company focused on developing drugs and therapies for age-related diseases
Peter ThielFounder of the Thiel Foundation, which supports research in anti-aging and life extension
Sergey YoungFounder of Longevity Vision Fund, a venture capital fund investing in companies developing technologies to extend human lifespan
Nir BarzilaiFounder of the Institute for Aging Research at the Albert Einstein College of Medicine, focused on developing interventions to delay aging and prevent age-related diseases
David SinclairCo-director of the Paul F. Glenn Center for the Biology of Aging Research at Harvard Medical School, focused on understanding the molecular mechanisms of aging and developing therapies to slow or reverse aging
Michael WestCEO of AgeX Therapeutics, a biotech company focused on developing stem cell-based therapies for age-related diseases
Bill AndrewsCEO of Sierra Sciences, a biotech company focused on developing drugs to extend human lifespan by targeting telomeres
Robert HaririCEO of Celularity, a biotech company focused on developing cellular therapies for age-related diseases
Kirsty KieferChief Development Officer at BioAge Labs, a biotech company focused on developing drugs to extend human lifespan by targeting the aging process
Kevin PerrottCEO of Turn Biotechnologies, a biotech company focused on developing small molecule drugs to target aging
Brian KennedyCEO of the Buck Institute for Research on Aging, focused on understanding the biology of aging and developing interventions to extend lifespan and prevent age-related diseases
Vadim GladyshevDirector of the Center for Aging and Regeneration at Brigham and Women’s Hospital, focused on understanding the molecular mechanisms of aging and developing interventions to slow or reverse aging
Judy CampisiProfessor at the Buck Institute for Research on Aging, focused on understanding the cellular and molecular mechanisms of aging and developing interventions to slow or reverse aging
Jan GruberAssociate Professor at Yale University, focused on understanding the molecular mechanisms of aging and developing interventions to extend lifespan and prevent age-related diseases
James PeyerFounder and CEO of Cambrian Biopharma, a biotech company focused on developing drugs to target aging
Jason HopePhilanthropist and investor in age-related research, focused on supporting research and development in anti-aging and life extension
Joon YunManaging Partner of Palo Alto Investors, focused on investing in companies developing technologies to extend human lifespan
Thomas RandoProfessor of Neurology and Neurological Sciences at Stanford University, focused on understanding the biology of aging and developing interventions to extend lifespan and prevent age-related diseases
Steven HorvathProfessor of Human Genetics and Biostatistics at UCLA, developed the epigenetic clock, a biomarker of aging that can be used to track the rate of aging
Greg FahyChief Science Officer of Intervene Immune, focused on developing interventions to slow or reverse aging by targeting the immune system
Tom GardnerFounder and CEO of The Motley Fool, investor in companies working on age-related diseases and life extension
Peter DiamandisFounder and Chairman of the XPRIZE Foundation, focused on incentivizing and accelerating breakthroughs in science and technology, including in the field of aging
Bryan JohnsonFounder of Kernel and OS Fund, invested in Project Blueprint focused
Jeff BezosFounder of Amazon and Bezos Family Foundation

Please note that this is by no means a complete list.

a30fa09a5083e238ea0386a12530401c?s=250&d=mm&r=g